Regions of the Retinoblastoma Gene Product Required for its Interaction with the E2F Transcription Factor are Necessary for E2 Promoter Repression and pRb-Mediated Growth Suppression

REFERENCES

• Bagchi, S., P. Raychaudhuri, and J. R. Nevins. 1990. Adenovirus E1A proteins can dissociate heteromeric complexes involving the E2F transcription factor: a novel mechanism for E1A trans-activation. Cell 62:659–669.
   PubMed Web of Science ®Google Scholar
• Bandara, L. R., J. P. Adamczewski, T. Hunt, and N. B. La Thangue. 1991. Cyclin A and the retinoblastoma gene product complex with a common transcription factor. Nature (London) 352:249–251.
   PubMed Web of Science ®Google Scholar
• Bandara, L. R., and N. B. La Thangue. 1991. Adenovirus E1a prevents the retinoblastoma gene product from complexing with a cellular transcription factor. Nature (London) 351:494–497.
   PubMed Web of Science ®Google Scholar
• Berger, J., J. Hauber, R. Hauber, R. Geiger, and B. R. Cullen. 1988. Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cells. Gene 66:1–10.
   PubMed Web of Science ®Google Scholar
• Blake, M. C., and J. C. Azizkhan. 1989. Transcription factor E2F is required for efficient expression of the hamster dihydro-folate reductase gene in vitro and in vivo. Mol. Cell. Biol. 9:4994–5002.
   PubMed Web of Science ®Google Scholar
• Buchkovich, K., L. A. Duffy, and E. Harlow. 1989. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58:1097–1105.
   PubMed Web of Science ®Google Scholar
• Cao, L., B. Faha, M. Dembski, L.-H. Tsai, E. Harlow, and N. Dyson. 1992. Independent binding of the retinoblastoma protein and pl07 to the transcription factor E2F. Nature (London) 355:176–179.
   PubMedGoogle Scholar
• Chellappan, S. P., S. Hiebert, M. Mudryj, J. M. Horowitz, and J. R. Nevins. 1991. The E2F transcription factor is a cellular target for the RB protein. Cell 65:1053–1061.
   PubMed Web of Science ®Google Scholar
• Chellappan, S. P., V. B. Kraus, B. Kroger, K. Munger, P. M. Howley, W. C. Phelps, and J. R. Nevins. 1992. E1A, T antigen, and E7 share the capacity to disrupt the E2F-Rb interaction. Proc. Natl. Acad. Sci. USA 89:4549–4553.
   PubMed Web of Science ®Google Scholar
• Chen, P. L., P. Scully, J.-Y. Shew, J. Y. J Wang, and W.-H. Lee. 1989. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 58:1193–1198.
   PubMed Web of Science ®Google Scholar
• Chittenden, T., D. M. Livingston, and W. G. Kaelin, Jr. 1991. The T-ElA-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein. Cell 65:1073–1082.
   PubMed Web of Science ®Google Scholar
• Dalton, S. 1992. Cell cycle regulation of the human cdc2 gene. EMBO J. 11:1797–1804.
   PubMed Web of Science ®Google Scholar
• DeCaprio, J. A., J. W. Ludlow, D. Lynch, Y. Furukawa, J. Griffin, H. Piwnica-Worms, C.-H. Huang, and D. M. Livingston. 1989. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 58:1085–1095.
   PubMed Web of Science ®Google Scholar
• Devoto, S. H., M. Mudryj, J. Pines, T. Hunter, and J. R. Nevins. 1992. A cyclin A-protein kinase complex possesses sequencespecific DNA binding activity: p33cdk2 is a component of the E2F-cyclin A complex. Cell 68:167–176.
   PubMed Web of Science ®Google Scholar
• Dou, Q.-P., J. L. Fridovich-Keil, and A. B. Pardee. 1991. Inducible proteins binding to the murine thymidine kinase promoter in late Gl/S phase. Proc. Natl. Acad. Sci. USA 88:1157–1161.
   PubMedGoogle Scholar
• Dyson, N., P. M. Howley, K. Munger, and E. Harlow. 1989. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243:934–937.
   PubMed Web of Science ®Google Scholar
• Ewen, M. E., H. K. Sluss, C. J. Sherr, H. Matsushime, J.-Y. Kato, and D. M. Livingston. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell, in press.
   Google Scholar
• Ewen, M. E., B. Faha, E. Harlow, and D. M. Livingston. 1992. Interaction of pl07 with cyclin A independent of complex formation with viral oncoproteins. Science 255:85–87.
   PubMed Web of Science ®Google Scholar
• Ewen, M. E., Y. Xing, J. B. Lawrence, and D. M. Livingston. 1991. Molecular cloning, chromosomal mapping and expression of the cDNA for pl07, a retinoblastoma gene product-related protein. Cell 66:1155–1164.
   PubMed Web of Science ®Google Scholar
• Faha, B., M. E. Ewen, L.-H. Tsai, D. M. Livingston, and E. Harlow. 1992. Interaction between human cyclin A and adeno-virus ElA-associated pl07 protein. Science 255:87–89.
   PubMed Web of Science ®Google Scholar
• Goodrich, D. W., N. P. Wang, Y.-W. Qian, E. Y.-H. P. Lee, and W.-H. Lee. 1991. The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell 67:293–302.
   PubMed Web of Science ®Google Scholar
• Gorman, C. M., L. F. Moffat, and B. H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyl-transferase in mammalian cells. Mol. Cell. Biol. 2:1044–1051.
   PubMed Web of Science ®Google Scholar
• Hamel, P. A., R. M. Gill, R. A. Phillips, and B. L. Gallie. 1992. Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene. Mol. Cell. Biol. 12:3431–3438.
   PubMed Web of Science ®Google Scholar
• Helin, K., J. A. Lees, M. Vidal, N. Dyson, E. Harlow, and A. Fattaey. 1992. A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell 70:337–350.
   PubMed Web of Science ®Google Scholar
• Hiebert, S. W., M. Blake, J. Azizkhan, and J. R. Nevins. 1991. Role of E2F transcription factor in ElA-mediated trans activation of cellular genes. J. Virol. 65:3547–3552.
   PubMedGoogle Scholar
• Hiebert, S. W., S. P. Chellappan, J. M. Horowitz, and J. R. Nevins. 1992. The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev. 6:177–185.
   PubMed Web of Science ®Google Scholar
• Hiebert, S. W., and R. A. Lamb. 1988. Cell surface expression of a glycosylated, nonglycosylated, and truncated forms of a cytoplasmic protein pyruvate kinase. J. Cell Biol. 107:865–876.
   PubMedGoogle Scholar
• Hiebert, S. W., M. Lipp, and J. R. Nevins. 1989. ElA-dependent trans-activation of the human MYC promoter is mediated by the E2F factor. Proc. Natl. Acad. Sci. USA 86:3594–3598.
   PubMed Web of Science ®Google Scholar
• Hinds, P. W., S. Mittnacht, V. Dulie, A. Arnold, S. I. Reed, and R. A. Weinberg. 1992. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70:9931006.
   Google Scholar
• Hu, Q., N. Dyson, and E. Harlow. 1990. The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutations. EMBO J. 9:1147–1155.
   PubMed Web of Science ®Google Scholar
• Kaelin, W. G., M. E. Ewen, and D. M. Livingston. 1990. Definition of the minimal simian virus 40 large T antigen- and adenovirus ElA-binding domain in the retinoblastoma gene product. Mol. Cell. Biol. 10:3761–3769.
   PubMed Web of Science ®Google Scholar
• Kaelin, W. G., Jr., W. Krek, W. R. Sellers, J. A. DeCaprio, F. Ajchenbaum, C. S. Fuchs, T. Chittenden, Y. Li, P. J. Farnham, M. A. Blanar, D. M. Livingston, and E. K. Flemington. 1992. Expression cloning of a cDNA encoding a retinoblastomabinding protein with E2F-like properties. Cell 70:351–364.
   PubMed Web of Science ®Google Scholar
• Kaelin, W. G., Jr., D. C. Pallas, J. A. DeCaprio, F. J. Kaye, and D. M. Livingston. 1991. Identification of cellular proteins that can interact specifically with the T/ElA-binding region of the retinoblastoma gene product. Cell 64:521–532.
   PubMed Web of Science ®Google Scholar
• Kato, J.-Y., H. Matsushime, S. W. Hiebert, M. E. Ewen, and C. J. Sherr. 1993. Direct binding of cyclin D to the retinoblas-toma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev. 7:331–342.
   PubMed Web of Science ®Google Scholar
• Lees, E., B. Faha, V. Dulic, S. I. Reed, and E. Harlow. 1992. Cyclin E/cdk2 and cyclin A/cdk2 kinases associated with pl07 and E2F in a temporally distinct manner. Genes Dev. 6:1874–1885.
   PubMed Web of Science ®Google Scholar
• Loeken, M. R., and J. Brady. 1989. The adenovirus EIIA enhancer. Analysis of regulatory sequences and changes in binding activity of ATF and EIIF following adenovirus infection. J. Biol. Chem. 264:6572–6579.
   PubMedGoogle Scholar
• Ludlow, J. W., J. A. DeCaprio, C.-M. Huang, W.-H. Lee, E. Paucha, and D. M. Livingston. 1989. SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family. Cell 56:57–65.
   PubMed Web of Science ®Google Scholar
• Matsushime, H., M. E. Ewen, D. K. Strom, J.-Y. Kato, S. K. Hanks, M. F. Roussel, and C. J. Sherr. 1992. Identification and properties of an atypical catalytic subunit (p34psk-j3/cdk4) for mammalian D type G1 cyclins. Cell 71:323–334.
   PubMed Web of Science ®Google Scholar
• Mudryj, M., S. H. Devoto, S. W. Hiebert, T. Hunter, J. Pines, and J. R. Nevins. 1991. Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A. Cell 65:1243–1253.
   PubMed Web of Science ®Google Scholar
• Mudryj, M., S. W. Hiebert, and J. R. Nevins. 1990. A role for the adenovirus inducible E2F transcription factor in a prolifer-ation-dependent signal transduction pathway. EMBO J. 7:2179–2184.
   Google Scholar
• Pagano, M., G. Draetta, and P. Jansen-Durr. 1992. Association of cdk2 kinase with the transcription factor E2F during S phase. Science 255:1144–1147.
   PubMedGoogle Scholar
• Phelps, W. C., S. Bagchi, J. A. Barnes, P. Raychaudhuri, V. Kraus, K. Mùnger, P. M. Howley, and J. R. Nevins. 1991. Analysis of trans activation by human papillomavirus type 16 E7 and adenovirus 12S E1A suggests a common mechanism. J. Virol. 65:6922–6930.
   PubMedGoogle Scholar
• Qin, X-Q., T. Chittenden, D. M. Livingston, and W. G. Kaelin, Jr. 1992. Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev. 6:953–964.
   PubMed Web of Science ®Google Scholar
• Ray, S. K., M. Arroyo, S. Bagchi, and P. Raychaudhuri. 1992. Identification of a 60-kilodalton Rb-binding protein, RBP60, that allows the Rb-E2F complex to bind DNA. Mol. Cell. Biol. 12:4327–4333.
   PubMedGoogle Scholar
• Raychaudhuri, P., S. Bagchi, S. H. Devoto, V. B. Kraus, E. Moran, and J. R. Nevins. 1991. Domains of the adenovirus E1A protein required for oncogenic activity are also required for dissociation of E2F transcription factor complexes. Genes Dev. 5:1200–1211.
   PubMedGoogle Scholar
• Robbins, P. D., J. M. Horowitz, and R. C. Mulligan. 1992. Negative regulation of human c-fos expression by the retino-blastoma gene product. Nature (London) 346:668–671.
   Google Scholar
• Scheffner, M., K. Munger, J. C. Byrne, and P. M. Howley. 1991. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc. Natl. Acad. Sci. USA 88:5523–5527.
   PubMed Web of Science ®Google Scholar
• Scholer, H. R., A. K. Hatzopoulos, R. Balling, N. Suzuki, and P. Gruss. 1989. A family of octamer-specific proteins present during mouse embryogenesis: evidence for germline-specific expression of an Oct factor. EMBO J. 8:2543–2550.
   PubMed Web of Science ®Google Scholar
• Shew, J. Y., B. T.-Y. Lin, P.-L. Chen, B. Y. Tseng, T. L. Yang-Feng, and W.-H. Lee. 1990. C-terminal truncation of the retinoblastoma gene product leads to functional inactivation. Proc. Natl. Acad. Sci. USA 87:6–10.
   PubMed Web of Science ®Google Scholar
• Shirodkar, S., M. Ewen, J. A. DeCaprio, J. Morgan, D. M. Livingston, and T. Chittenden. 1992. The transcription factor E2F interacts with the retinoblastoma product and a pl07-cyclin A complex in a cell cycle-regulated manner. Cell 68:157–166.
   PubMed Web of Science ®Google Scholar
• Smith, D. B., and K. S. Johnson. 1988. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67:31–40.
   PubMed Web of Science ®Google Scholar
• Thalmeier, K., H. Synovzik, R. Mertz, E.-L. Winnacker, and M. Lipp. 1989. Nuclear factor E2F mediates basic transcription and trans-activation by E1a of the human myc promoter. Genes Dev. 3:527–536.
   PubMedGoogle Scholar
• Weinberg, R. A. 1991. Tumor suppressor genes. Science 254:1138–1146.
   PubMed Web of Science ®Google Scholar
• Weintraub, S. J., C. A. Prater, and D. C. Dean. 1992. Retinoblastoma protein switches the E2F site from positive to negative element. Nature (London) 358:259–261.
   PubMed Web of Science ®Google Scholar
• Whyte, P., K. J. Buchkovich, J. M. Horowitz, S. H. Friend, M. Raybuck, R. A. Weinberg, and E. Harlow. 1988. Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature (London) 334:124–129.
   PubMed Web of Science ®Google Scholar
• Yee, A. S., P. Raychaudhuri, L. Jakoi, and J. R. Nevins. 1989. The adenovirus-inducible factor E2F stimulates transcription after specific DNA binding. Mol. Cell. Biol. 9:578–585.
   PubMedGoogle Scholar